ACTIVEAffiliate Disclosure: We may earn commissions from partner links. Details
Consumer Safety Resource

GLP-1 Safety Center

Your independent safety resource for GLP-1 medications. We track FDA enforcement actions, document side effects, verify providers, and follow active litigation so you can make informed decisions.

By GLP-1 Watchdog Editorial TeamIndependent Health Research
Published: March 28, 2026|Updated: March 30, 2026
50+FDA Warning LettersIssued to compounders in 2025-2026
40-70%GI Side EffectsMost common adverse reaction
30M+Americans on GLP-1sAnd growing rapidly
$6B+In Active LawsuitsAgainst GLP-1 manufacturers
Health

Side Effects Guide

Comprehensive breakdown of GLP-1 side effects from common GI issues to rare but serious complications. Know what to expect and when to seek help.

Read More
Management

Managing Side Effects

Practical, evidence-based strategies for managing common GLP-1 side effects like nausea, constipation, and fatigue. Tips from gastroenterologists and patients.

Read More
Alerts

FDA Safety Alerts

Real-time tracking of FDA warning letters, recalls, and enforcement actions against GLP-1 compounders and distributors.

Read More
Legal

Lawsuit Tracker

Follow active GLP-1 litigation including class actions against Novo Nordisk and Eli Lilly. Understand the legal landscape.

Read More
Verification

Scam Checker

Verify if your GLP-1 provider is legitimate. Red flags, green flags, and a step-by-step checklist to protect yourself from fraud.

Read More
Pregnancy

Ozempic & Pregnancy

Critical safety information about GLP-1 medications and pregnancy. When to stop, waiting periods, fertility effects, and what the FDA recommends.

Read More

Warning: Compounded GLP-1 Medications

The FDA declared the semaglutide shortage officially over in February 2025, removing the legal basis for most compounding pharmacies to produce semaglutide copies. Despite this, many compounders continue to sell compounded semaglutide illegally.

  • The FDA has issued warning letters to 50+ compounders for contamination, incorrect dosing, and use of unapproved salt forms
  • Some compounded products have been found to contain dangerously incorrect concentrations of semaglutide
  • Compounded medications do not undergo the same quality testing as FDA-approved drugs
  • Several patients have reported serious adverse events linked to compounded GLP-1 products

Essential Safety Tips

01

Verify Your Provider

Always confirm your provider uses state-licensed pharmacies and has verifiable, named physicians on staff.

02

Start Low, Go Slow

GLP-1 medications should be titrated gradually. Any provider shipping you a high dose immediately is a red flag.

03

Report Problems

Report adverse events to the FDA MedWatch program and your state pharmacy board. Your report could protect others.

Not Sure About Your Provider?

Use our scam checker to verify legitimacy, or see our independently ranked providers.

Find Your GLP-1 Match — Free Quiz